Clinical Trial Update: Trial of Adalimumab in Progressive Sarcoidosis [Phase 2]

View source ↗

Summary

Phase 2 trial of adalimumab in progressive sarcoidosis was terminated; results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: University of Chicago | Conditions: Sarcoidosis | Phase 2 | Status: TERMINATED | Results posted: 2020-08-14